Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7701–7750 of 75441
Effective as of July 30, 2024, Rose M. Sparks resigned from the Board of Directors (the “Board”) of FutureFuel Corp. (the “Company”).
On August 2, 2024, Ms. Cheng Sin Yi notified the Company of her resignation from all her positions with the Company, including Secretary and Treasurer, effective as of the close of business on August 2, 2024.
Tang Siu Fung notified Flywheel Advanced Technology, Inc. (the “Company”) of his resignation from all his positions with the Company, including sole director, Chief Executive Officer and President, effective as of the close of business on July 30, 2024.
On July 31, 2024, Eric Liaw notified ZipRecruiter, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), including from the Audit Committee of the Board (the “Audit Committee”) and the Compensation Committee of the Board (the “Compensation Committee”), effective immediately.
Kevin Smith ceased to serve in his capacity as Executive Vice President, Chief Product Officer, effective as of July 10, 2024.
On June 27, 2024, Ovid Therapeutics Inc. (the “Company”) announced that Thomas Perone, the Company’s former General Counsel, Chief Compliance Officer and Corporate Secretary, would be departing from the Company in those roles, effective as of July 11, 2024 (the “Separation Date”) in connection with a workforce reduction.
On August 2, 2024, Ms. Katrinka McCallum, a member of the Board of Directors (the “ Board ”) of Rimini Street, Inc. (the “ Company ”), delivered her written resignation as a member of the Board effective as of August 2, 2024 to pursue other endeavors.
each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board
each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board
each of Avraham Ben-Tzvi, Matthew C. McMurdo and David Natan delivered notice of their resignation as a member of the Board
On July 29, 2024, Nicholas J. Bigney, General Counsel of Nauticus Robotics, Inc., ("Nauticus") informed the Nauticus of his intention to resign from his position to accept a position with a different company.
Steve Sanghi, the Company’s Executive Chair, informed the Company of his retirement as an officer and employee of the Company effective at the end of the day on August 20, 2024.
The acceleration was in relation to Mr. Haberman's August 6, 2024 retirement as Executive Vice President of the Company's Industrial Equipment Division as previously disclosed in a Current Report on Form 8-K filed with the Securities Exchange Commission (the "SEC") on June 10, 2024.
Hemanth Munipalli will resign from his position with the Company effective August 19, 2024.
Rene Yoakum, the Company’s EVP, Customer and Culture provided notice that she will retire from the Company effective December 31, 2024.
On July 31, 2024, Craig Boelte, Chief Financial Officer of Paycom Software, Inc. (the “Company”), notified the Board of Directors of the Company that he intends to retire from his role as Chief Financial Officer in the next nine to 12 months.
Effective August 1, 2024, James Hazlett retired as our Chief Technical Officer and separated his employment from the Company.
Effective as of July 26, 2024, Osman Ahmed resigned and stepped down from the Board of Directors (the “Board”) of African Agriculture Holdings, Inc. (the “Company”).
On July 26, 2024, Mark Forman, M.D., Ph.D., notified the Company of his decision to resign from his position as the Company’s Chief Medical Officer, effective as of August 2, 2024.
Rocco A. Ortenzio, a director of Select Medical Holdings Corporation (the “Company”), notified the Company of his decision to resign as a director, effective August 1, 2024.
On August 1, 2024, the Company announced that Liz Fraser, the CEO & Brand President of Kate Spade, will be leaving the Company.
Dr. Jamil succeeds Dr. Pol Boudes as Chief Medical Officer of the Company, who resigned on July 26, 2024. Dr. Boudes’s last day of employment with the Company is August 1, 2024.
On July 29, 2024, Groove Botanicals Inc. (the “Company”) received the resignation of Mr. Douglas Barton as a director of the Company.
Effective July 26, 2024, Neil J. Laird resigned as the chief financial officer of NovAccess Global Inc.
the elimination of the position of Chief Technology Officer effective August 9, 2024 and the related departure from the Company of Pierre-Olivier Latour
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
each of the directors of Cerevel (Tony Coles, M.D., Ron Renaud, Marijn Dekkers, Ph.D., Douglas Giordano, Chris Gordon, Adam Koppel, M.D., Ph.D., Norbert Riedel, Ph.D., Gabrielle Sulzberger, Ruth McKernan, Ph.D., Deval Patrick, Deborah Baron and Suneet Varma) resigned from the Board.
Kevin Hough, who has stepped down, effective August 1, 2024, from his role as interim Executive Vice President and Chief Financial Officer.
With the exception of Ms. Sammie Long, who retired from her position at the Company effective July 31, 2024
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Pursuant to the Merger Agreement, at the Effective Time, Kelly Baker, William Brundage, Geoffrey Drabble, Catherine Halligan, Brian May, James Metcalf, Kevin Murphy, Alan Murray, Nadia Shouraboura, Thomas Schmitt and Suzanne Wood each ceased to be directors of the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.